Description

Tirzepatide 30mg is a synthetic dual receptor agonist peptide supplied in a high-purity lyophilized form for laboratory and scientific research purposes. It is widely studied in experimental models involving metabolic signaling pathways, energy homeostasis regulation, and multi-receptor peptide interactions.

Manufactured under strict quality control standards, Tirzepatide is designed to ensure consistency, stability, and reproducibility in advanced research applications.

Key Features

• High-Purity Research Grade Peptide
• 30mg Per Vial Concentration for advanced laboratory studies
• Dual GIP / GLP-1 Receptor Agonist Model for metabolic research
• Sterile Lyophilized Powder Form for enhanced stability and shelf life
• Batch-Tested Quality Assurance with COA availability

Specifications

• Product Name: Tirzepatide
• Strength: 30mg per vial
• Form: Freeze-dried (lyophilized) powder
• Type: Synthetic dual incretin receptor agonist peptide
• Storage: Store in a cool, dry place. Refrigeration recommended after reconstitution in research environments
• Purity: ≥ 99% (subject to batch COA verification)
• Usage: Laboratory and scientific research only

Packaging

Each vial is securely sealed in sterile, tamper-resistant packaging to maintain product integrity and stability. Every unit includes a unique batch identifier for traceability and quality assurance.

Quality Control

Each batch may undergo rigorous analytical testing, including:

• High-Performance Liquid Chromatography (HPLC)
• Mass Spectrometry (if applicable)
• Identity and purity verification
• Certificate of Analysis (COA) availability per batch

Important Notice

This product is intended strictly for research and laboratory purposes only. It is not intended for human consumption, medical use, diagnosis, or therapeutic application.